CD8A and neoplasm: In one study, MHC class I and class II-restricted MART1 tumor peptides loaded onto Dex in acidic conditions bound to MHC molecules with high affinity and activated CD8+ CTL and CD4+ T-cell responses after processing by DCs [94].